TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 30106963

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine supplemented morphine analgesia (0.5 mg/ml morphine plus 2 μg/ml dexmedetomidine in 100 ml normal saline)
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine supplemented morphine analgesia
Number of subjects: 58

Group type: COMPARATOR
Intervention: Morphine analgesia
Number of subjects: 58
Study: 26345103

Group type: EXPERIMENTAL
Intervention: CAF with oblique interdental incisions (OBL technique)
Number of subjects: 10

Group type: COMPARATOR
Intervention: CAF with horizontal interdental incisions (HOR technique)
Number of subjects: 10
Study: 25011433

Group type: EXPERIMENTAL
Intervention: Neuromuscular electrical stimulation
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control (Conventional exercises and static volar wrist-hand orthosis)
Number of subjects: 24
Study: 22526864

Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Transdermal tulobuterol patch
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Inhaled salmeterol and transdermal tulobuterol patch
Number of subjects: 36
Study: 20500876

Group type: EXPERIMENTAL
Intervention: 7.2% hypertonic saline with 6% poly (O‐2‐hydroxyethyl) starch solution (HH)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Standard fluid therapy (Ringer's Acetate and saline 9 mg/ml) (control)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Crystalloids
Number of subjects: 19
Study: 18382668

Group type: EXPERIMENTAL
Intervention: 1100 MBq (30 mCi) of radioiodine (131I)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: 3700 MBq (100 mCi) of radioiodine (131I)
Number of subjects: 160
Study: 16339664

Group type: EXPERIMENTAL
Intervention: ICL670, a once-daily oral iron chelator
Number of subjects: 264
Study: 12550812

Group type: EXPERIMENTAL
Intervention: Chronic anterior cruciate ligament deficient subjects prior to surgery
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Chronic anterior cruciate ligament deficient subjects following surgery
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 10778276

Group type: EXPERIMENTAL
Intervention: Aversive stimulation with failure on a bogus intelligence test
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonaversive stimulation with failure on a bogus intelligence test
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Aversive stimulation with success on a bogus intelligence test
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nonaversive stimulation with success on a bogus intelligence test
Number of subjects: 40
Study: 9165691

Group type: EXPERIMENTAL
Intervention: Intravenous proton pump inhibitors (80 mg pantoprazole or omeprazole bolus followed by 8 mg/hour continuous infusion)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 1642186

Group type: EXPERIMENTAL
Intervention: Enalapril (2.5 to 40 mg/day)
Number of subjects: 243

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study: 6133546

Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg twice daily)
Number of subjects: 6
Study: 31006300

Group type: EXPERIMENTAL
Intervention: Supportive care and selective medical management
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Supportive care
Number of subjects: 294
Study: 29627940

Group type: EXPERIMENTAL
Intervention: Motor rehabilitation (4-week neurorehabilitation)
Number of subjects: 29
Study: 26924419

Group type: EXPERIMENTAL
Intervention: Intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 24149241

Group type: EXPERIMENTAL
Intervention: Immobilization of the left hand for 24 hours (experimental group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no immobilization)
Number of subjects: 0
Study: 23672109

Group type: EXPERIMENTAL
Intervention: Intravenous Paracetamol 1g diluted to 20 mls with normal saline
Number of subjects: 56

Group type: COMPARATOR
Intervention: Intravenous normal saline 20 mls
Number of subjects: 56
Study: 19582757

Group type: EXPERIMENTAL
Intervention: Individualized functional enhancement program (FEP)
Number of subjects: 74

Group type: COMPARATOR
Intervention: General occupational therapy (Control)
Number of subjects: 74
Study: 17599439

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SESs)
Number of subjects: 2769

Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PESs)
Number of subjects: 2769
Study: 16128356

Group type: EXPERIMENTAL
Intervention: RDC/TMD examination protocol
Number of subjects: 24
Study: 12103382

Group type: EXPERIMENTAL
Intervention: Renal-dose dopamine infusion (3 microg kg(‐1) min(‐1)) for 48 hours
Number of subjects: 50

Group type: COMPARATOR
Intervention: Saline infusion (placebo)
Number of subjects: 50
Study: 10408031

Group type: EXPERIMENTAL
Intervention: Simvastatin (S) 40 mg daily
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Simvastatin (S)
Number of subjects: 254

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 254
Study: 7970425

Group type: EXPERIMENTAL
Intervention: Metastron (89Sr-chloride)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study: 3555578

Group type: EXPERIMENTAL
Intervention: Guanfacine (2 mg once daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 29526608

Group type: EXPERIMENTAL
Intervention: Vitamin D (2000 IU/day)
Number of subjects: 25874

Group type: EXPERIMENTAL
Intervention: Marine omega-3 fatty acids (1g/day)
Number of subjects: 25874

Group type: EXPERIMENTAL
Intervention: Vitamin D among African-Americans (at-risk group)
Number of subjects: 25874

Group type: EXPERIMENTAL
Intervention: Both agents among participants with high-risk factors or sub-syndromal depression
Number of subjects: 25874

Group type: EXPERIMENTAL
Intervention: Baseline nutrient levels
Number of subjects: 25874

Group type: EXPERIMENTAL
Intervention: Key biomarkers and factors from pre-randomization blood samples
Number of subjects: 25874
Study: 26242380

Group type: EXPERIMENTAL
Intervention: Daclizumab high-yield process (DAC HYP) 50-300 mg subcutaneous and 200-400 mg intravenous doses
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 25399229

Group type: EXPERIMENTAL
Intervention: Paclitaxel (175 mg/m(2))
Number of subjects: 481

Group type: COMPARATOR
Intervention: Docetaxel (75 mg/m(2))
Number of subjects: 481

Group type: EXPERIMENTAL
Intervention: Paclitaxel
Number of subjects: 481

Group type: COMPARATOR
Intervention: Docetaxel
Number of subjects: 481
Study: 22672447

Group type: EXPERIMENTAL
Intervention: Primary anastomosis (PRA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Nonrestorative colon resection
Number of subjects: 90
Study: 20142302

Group type: COMPARATOR
Intervention: THC
Number of subjects: 35

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Haloperidol + THC
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 18515519

Group type: EXPERIMENTAL
Intervention: Betamethasone (active), four or more courses
Number of subjects: 205

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 205
Study: 15747272

Group type: EXPERIMENTAL
Intervention: Rofecoxib, 50 mg, 1 hour before surgery
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 12593019

Group type: EXPERIMENTAL
Intervention: Transurethral electrovaporization of prostate (TUVP)
Number of subjects: 206

Group type: COMPARATOR
Intervention: Transurethral resection of prostate (TURP)
Number of subjects: 206
Study: 10371471

Group type: EXPERIMENTAL
Intervention: Intravenous gentamicin, 5 mg/kg over 60 min, max dose 500 mg (Group I)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Intravenous gentamicin dosed according to a formula for desired peak concentration of 14 mg/L (Group II)
Number of subjects: 22
Study: 8873731

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass at 37 degrees C
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass at 32 degrees C
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Cardiopulmonary bypass at 28 degrees C
Number of subjects: 96
Study: 1744909

Group type: EXPERIMENTAL
Intervention: Relaxation therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hygiene alone
Number of subjects: 0
Study: 6852098

Group type: EXPERIMENTAL
Intervention: Tilidine (100 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Tilidine (100 mg); Naloxone (8 mg)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Naloxone (32 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Tilidine (100 mg); Naloxone (32 mg)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Naloxone
Number of subjects: 15
Study: 31703120

Group type: EXPERIMENTAL
Intervention: Vitamin D3 (2000 IU/d)
Number of subjects: 1312

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acids (1 g/d)
Number of subjects: 1312

Group type: COMPARATOR
Intervention: Placebo (for both vitamin D3 and omega-3)
Number of subjects: 1312
Study: 27844124

Group type: EXPERIMENTAL
Intervention: Multidisciplinary treatment program
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 155
Study: 24306109

Group type: EXPERIMENTAL
Intervention: Bone area measurement in OA participants
Number of subjects: 2197

Group type: EXPERIMENTAL
Intervention: Bone area change
Number of subjects: 2197

Group type: EXPERIMENTAL
Intervention: Cartilage thickness measure (cMFTC)
Number of subjects: 2197

Group type: EXPERIMENTAL
Intervention: Joint space width (JSW)
Number of subjects: 2197

Group type: EXPERIMENTAL
Intervention: Body mass index, gender, and alignment
Number of subjects: 2197
Study: 24141882

Group type: EXPERIMENTAL
Intervention: Prepuncture ultrasound examination in lean parturients (group 1, n=25)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Prepuncture ultrasound examination in obese parturients (group 2, n=25)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional technique in obese parturients (group 4, n=25)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional technique in lean parturients (group 3, n=25)
Number of subjects: 100
Study: 22390465

Group type: EXPERIMENTAL
Intervention: Auditory lexical decision task with phonological and semantic manipulation
Number of subjects: 0
Study: 19437058

Group type: EXPERIMENTAL
Intervention: Coconut oil (30 mL daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Soybean oil (30 mL daily)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups (Coconut oil and Soybean oil)
Number of subjects: 40
Study: 17296823

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 4958

Group type: COMPARATOR
Intervention: Bare-metal stents
Number of subjects: 4958
Study: 14872552

Group type: EXPERIMENTAL
Intervention: Lescol XL 80 mg once a day for 7 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lescol XL 160 mg once a day for 7 days
Number of subjects: 12

Group type: COMPARATOR
Intervention: Lescol IR 40 mg twice a day for 7 days
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lescol XL 80 mg and 160 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lescol XL 160 mg
Number of subjects: 12
Study: 11684539

Group type: EXPERIMENTAL
Intervention: Carbohydrate drink (glucose)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Fat drink (safflower oil)
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Protein drink (whey)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Non-energy placebo
Number of subjects: 22
Study: 9839524

Group type: EXPERIMENTAL
Intervention: Soymilk-supplemented diet (400 mL daily, containing about 109 mg of isoflavones)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal diet (control)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Soymilk-supplemented diet
Number of subjects: 60
Study: 7654800

Group type: EXPERIMENTAL
Intervention: Physician referrals from affiliated clinics
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Free and low-cost recruitment methods
Number of subjects: 108
Study: 2398199

Group type: EXPERIMENTAL
Intervention: 23.4% hypertonic saline (HS)
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: 1% polidocanol (POL)
Number of subjects: 113

Group type: COMPARATOR
Intervention: Both HS and 1% POL
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: 0.5% POL (subgroup treatment for TM)
Number of subjects: 113
Study: 6778186

Group type: EXPERIMENTAL
Intervention: Intravenous tocainide administered over a 15-minute period
Number of subjects: 0

Group type: COMPARATOR
Intervention: Tocainide over a 24-hour period
Number of subjects: 0
Study: 30848867

Group type: EXPERIMENTAL
Intervention: Maternal education level
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Provision of foods especially purchased or prepared for IYC
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Maternal care
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Minimum dietary diversity (MDD)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Minimum meal frequency (MMF)
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: Minimum acceptable diet (MAD)
Number of subjects: 204
Study: 28364105

Group type: EXPERIMENTAL
Intervention: Telephone follow-up with written instruction
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control group (no telephone follow-up)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Telephone follow-up
Number of subjects: 160
Study: 26001666

Group type: EXPERIMENTAL
Intervention: Body-mind relaxation meditation induction (BMRMI)
Number of subjects: 21
Study: 24630487

Group type: EXPERIMENTAL
Intervention: Pain severity
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Pain catastrophizing
Number of subjects: 75
Study: 22237162

Group type: EXPERIMENTAL
Intervention: APF gel (1.23% F) application for 1 min
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: APF gel (1.23% F) application for 4 min
Number of subjects: 16

Group type: COMPARATOR
Intervention: No APF application (negative control)
Number of subjects: 16
Study: 19444907

Group type: EXPERIMENTAL
Intervention: Increasing plasma ferritin levels
Number of subjects: 1634

Group type: EXPERIMENTAL
Intervention: Dietary iron intake
Number of subjects: 1634
Study: 17558359

Group type: COMPARATOR
Intervention: Continuous Scale Physical Functional Performance Test (CS-PFP) for nondisabled adults
Number of subjects: 179

Group type: COMPARATOR
Intervention: Continuous Scale Physical Functional Performance Test (CS-PFP) for individuals with PD
Number of subjects: 179

Group type: COMPARATOR
Intervention: Continuous Scale Physical Functional Performance Test (CS-PFP) for nondisabled middle-aged individuals
Number of subjects: 179
Study: 15194901

Group type: EXPERIMENTAL
Intervention: Atomoxetine treatment for ADHD
Number of subjects: 297

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297
Study: 11598848

Group type: EXPERIMENTAL
Intervention: 11-valent pneumococcal conjugate vaccine with aluminum adjuvant
Number of subjects: 0

Group type: COMPARATOR
Intervention: 11-valent pneumococcal conjugate vaccine without aluminum adjuvant
Number of subjects: 0
Study: 9844044

Group type: EXPERIMENTAL
Intervention: Tetravalent (ACYW) meningococcal capsular polysaccharide vaccine
Number of subjects: 53

Group type: COMPARATOR
Intervention: Control group (non-complement-deficient relatives and healthy non-related controls)
Number of subjects: 53
Study: 8079927

Group type: EXPERIMENTAL
Intervention: Sucralfate (1 g four times daily for 30 days), tetracycline (500 mg four times daily for 10 days), tinidazol (500 mg three times daily for 10 days)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Ranitidine (150 mg twice daily for 30 days)
Number of subjects: 43
Study: 2647007

Group type: EXPERIMENTAL
Intervention: 450 mg enprofylline twice daily
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: 300 mg enprofylline twice daily
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: 150 mg enprofylline twice daily
Number of subjects: 206

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 206

Group type: EXPERIMENTAL
Intervention: 450 mg and 300 mg enprofylline
Number of subjects: 206

Group type: COMPARATOR
Intervention: 150 mg enprofylline and Placebo
Number of subjects: 206
Study: 31984531

Group type: EXPERIMENTAL
Intervention: Anger management skills training
Number of subjects: 60
Study: 30616984

Group type: EXPERIMENTAL
Intervention: Treadmill-slip-training group (Tt)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Treadmill-control group (Tc)
Number of subjects: 166

Group type: EXPERIMENTAL
Intervention: Over-ground-slip training group (Ot)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Over-ground walking group (Oc)
Number of subjects: 166
Study: 28232939

Group type: EXPERIMENTAL
Intervention: Classic group (surgical repair with mesh on the floor of the canal)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Preperitoneal group (surgical repair with mesh under the canal)
Number of subjects: 150
Study: 25978688

Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration Group (WBVG)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Multi-Component Training Group (MTG)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 38
Study: 23999656

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral intervention delivered over 11 one-hour weekly sessions and 2 booster sessions by trained nonspecialists.
Number of subjects: 2512

Group type: COMPARATOR
Intervention: Standard school curriculum (control group).
Number of subjects: 2512
Study: 21200338

Group type: EXPERIMENTAL
Intervention: Acute resistance exercise protocol (six sets of five-repetition maximum heavy squats)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control test (identical conditions with no exercise)
Number of subjects: 15
Study: 19491420

Group type: EXPERIMENTAL
Intervention: Folic acid 5 mg for 8 weeks
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (30 subjects without UA)
Number of subjects: 52
Study: 17206696

Group type: EXPERIMENTAL
Intervention: Lactobacillus johnsonii, LA1 (1010 CFU daily for 12 weeks)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Lactobacillus johnsonii, LA1
Number of subjects: 70
Study: 15285603

Group type: EXPERIMENTAL
Intervention: Formal logical reasoning
Number of subjects: 0
Study: 11584187

Group type: EXPERIMENTAL
Intervention: SNAC heparin (two different doses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: LMWH (subcutaneous injection)
Number of subjects: 0
Study: 9425671

Group type: EXPERIMENTAL
Intervention: Externally cued selection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Internally generated selection
Number of subjects: 0
Study: 8310560

Group type: EXPERIMENTAL
Intervention: Combined radiation, drug and estrogen treatments (II)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Combined estrogens and radiation (IV)
Number of subjects: 111

Group type: EXPERIMENTAL
Intervention: Radiation treatment alone (I)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Estrogen therapy alone (III)
Number of subjects: 111
Study: 2426899

Group type: EXPERIMENTAL
Intervention: Oral contraceptive containing 0.030 mg ethinylestradiol (EE) plus 0.150 mg levonorgestrel
Number of subjects: 48

Group type: COMPARATOR
Intervention: Oral contraceptive containing 0.150 mg levonorgestrel
Number of subjects: 48
Study: 31495419

Group type: EXPERIMENTAL
Intervention: Equine-assisted therapy
Number of subjects: 20
Study: 28939330

Group type: EXPERIMENTAL
Intervention: Physical activity programme in the aquatic environment (6 weeks)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Routine care (Control group)
Number of subjects: 46
Study: 27225520

Group type: EXPERIMENTAL
Intervention: Early-term isolated oligohydramnios
Number of subjects: 1213

Group type: COMPARATOR
Intervention: Full-term isolated oligohydramnios
Number of subjects: 1213

Group type: EXPERIMENTAL
Intervention: Late-term isolated oligohydramnios
Number of subjects: 1213

Group type: EXPERIMENTAL
Intervention: Timing of delivery (early-term, full-term, late-term)
Number of subjects: 1213

Group type: EXPERIMENTAL
Intervention: Isolated oligohydramnios cases
Number of subjects: 1213
Study: 25074507

Group type: EXPERIMENTAL
Intervention: Nesiritide
Number of subjects: 7141

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7141

Group type: EXPERIMENTAL
Intervention: Nesiritide and Placebo
Number of subjects: 7141
Study: 22607726

Group type: EXPERIMENTAL
Intervention: Nurse-managed telephone support line and colorectal cancer screening website
Number of subjects: 2280

Group type: COMPARATOR
Intervention: Standard clinical practice (control)
Number of subjects: 2280
Study: 19764907

Group type: EXPERIMENTAL
Intervention: Video Intubation Unit (VIU)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional laryngoscopy (Control)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 40
Study: 17912998

Group type: EXPERIMENTAL
Intervention: Ultreo ultrasound power toothbrush (ULT)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Manual toothbrush (Oral-B 35-MTB)
Number of subjects: 53
Study: 15629217

Group type: EXPERIMENTAL
Intervention: Central gaze cues
Number of subjects: 0

Group type: COMPARATOR
Intervention: Peripheral onset target with an equivalent distractor at the mirror opposite location
Number of subjects: 0
Study: 12001058

Group type: EXPERIMENTAL
Intervention: Thalidomide 50 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Thalidomide 100 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Thalidomide 150 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Thalidomide (all doses)
Number of subjects: 36
Study: 10469288

Group type: EXPERIMENTAL
Intervention: HRT (estrogen alone or with progestins)
Number of subjects: 293

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 293
Study: 8652952

Group type: EXPERIMENTAL
Intervention: Intranasal desmopressin (Desmospray) 40 micrograms for up to 6 weeks
Number of subjects: 71

Group type: COMPARATOR
Intervention: Enuresis alarm
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Combined treatment (enuresis alarm + desmopressin)
Number of subjects: 71
Study: 2213631

Group type: EXPERIMENTAL
Intervention: Bair Hugger Warming System
Number of subjects: 91

Group type: COMPARATOR
Intervention: Warmed bath blankets
Number of subjects: 91
Study: 386390

Group type: EXPERIMENTAL
Intervention: Viloxazine (300 mg/d)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Amitriptyline (150 mg/d)
Number of subjects: 41